Comparison of M-FISH and conventional cytogenetic analysis in accelerated and acute phases of CML

被引:4
作者
Brizard, F
Cividin, M
Villalva, C
Guilhot, F
Brizard, A
机构
[1] Univ Poitiers Hosp, CHU Miletrie, Lab Hematol EA 2224, F-86021 Poitiers, France
[2] Univ Poitiers Hosp, Serv Oncol Hematol & Therapie Cellulaire, UPRES EA 2622, Poitiers, France
关键词
CML; accelerated phase; blast crisis; M-FISH;
D O I
10.1016/j.leukres.2003.08.005
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
FISH and multicolor FISH (M-FISH) techniques have greatly enhanced the resolution of conventional cytogenetic analysis, thus enabling the identification of novel regions of rearrangement in hematological malignancies. We report on the analysis of cells from 24 chronic myelogenous leukemia (CML) patients, in either accelerated phase (14 cases) or blast crisis (10 cases) aimed at searching for previously unidentified additional abnormalities related to disease evolution. Indeed, in 6 of 24 cases (25%) M-FISH allowed a more precise description of chromosomal aberrations, the finding of cryptic rearrangements, characterization of markers, identification of additional material and a better interpretation of complex aberrations. However, new recurrent aberration did not emerge from M-FISH analysis. (C) 2003 Elsevier Ltd. All rights reserved.
引用
收藏
页码:345 / 348
页数:4
相关论文
共 23 条
[1]   Multicolor COBRA-FISH analysis of chronic myeloid leukemia reveals novel cryptic balanced translocations during disease progression [J].
Barbouti, A ;
Johansson, B ;
Höglund, M ;
Mauritzson, N ;
Strömbeck, B ;
Nilsson, PG ;
Tanke, HJ ;
Hagemeijer, A ;
Mitelman, F ;
Fioretos, T .
GENES CHROMOSOMES & CANCER, 2002, 35 (02) :127-137
[2]  
CALABRESE G, 2000, CANCER GENET CYTOGEN, V116, P105
[3]   Mechanisms of disease - The biology of chronic myeloid leukemia [J].
Faderl, S ;
Talpaz, M ;
Estrov, Z ;
O'Brien, S ;
Kurzrock, R ;
Kantarjian, HM .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (03) :164-172
[4]   Increased karyotype precision using fluorescence in situ hybridization and spectral karyotyping in patients with myeloid malignancies [J].
Fleischman, EW ;
Reshmi, S ;
Sokova, OI ;
Kirichenko, OP ;
Konstantinova, LN ;
Kulagina, OE ;
Frenkel, MA ;
Rowley, JD .
CANCER GENETICS AND CYTOGENETICS, 1999, 108 (02) :166-170
[5]   Cytogenetics of the chronic myeloid leukemia-derived cell line K562: Karyotype clarification by multicolor fluorescence in situ hybridization, comparative genomic hybridization, and locus-specific fluorescence in situ hybridization [J].
Gribble, SM ;
Roberts, I ;
Grace, C ;
Andrews, KM ;
Green, AR ;
Nacheva, EP .
CANCER GENETICS AND CYTOGENETICS, 2000, 118 (01) :1-8
[6]   Multiplex fluorescence in situ hybridization and cross species color banding of a case of chronic myeloid leukemia in blastic crisis with a complex Philadelphia translocation [J].
Harrison, CJ ;
Gibbons, B ;
Yang, FT ;
Butler, T ;
Cheung, KL ;
Kearney, L ;
Dirscherl, L ;
Bray-Ward, P ;
Gregson, M ;
Ferguson-Smith, M .
CANCER GENETICS AND CYTOGENETICS, 2000, 116 (02) :105-110
[7]   Spectral karyotyping and fluorescence in situ hybridization detect novel chromosomal aberrations, a recurring involvement of chromosome 21 and amplification of the MYC oncogene in acute myeloid leukaemia M2 [J].
Hilgenfeld, E ;
Padilla-Nash, H ;
McNeil, N ;
Knutsen, T ;
Montagna, C ;
Tchinda, J ;
Horst, J ;
Ludwig, WD ;
Serve, H ;
Büchner, T ;
Berdel, WE ;
Schröck, E ;
Ried, T .
BRITISH JOURNAL OF HAEMATOLOGY, 2001, 113 (02) :305-317
[8]  
Jalal SM, 1999, GENET MED, V1, P181
[9]   Detection of diagnostically critical, often hidden, anomalies in complex karyotypes of haematological disorders using multicolour fluorescence in situ hybridization [J].
Jalal, SM ;
Law, ME ;
Stamberg, J ;
Fonseca, R ;
Seely, JR ;
Myers, WH ;
Hanson, CA .
BRITISH JOURNAL OF HAEMATOLOGY, 2001, 112 (04) :975-980
[10]  
KANTARJIAN HM, 1988, CANCER, V61, P1441, DOI 10.1002/1097-0142(19880401)61:7<1441::AID-CNCR2820610727>3.0.CO